blue cross blue shield federal glp 1 coverage Why we are changing of GLP-1 drugs for weight loss GLP-1 | Blue Cross and

doi: 10.1177/1073858420975711 88 KannerAM

Bal M et al

5 Examples of GLP-1 receptor agonist injections include liraglutide (Saxenda), semaglutide (Ozempic for diabetes, Wegovy for obesity), and dulaglutide (Trulicity, primarily for diabetes but with potential off-label use for obesity)

But one gets better on its own

The trial established the IGF-1 axis as a clinical therapeutic target and supports the broader pharmacological rationale for IGF-1 receptor agonism, of which IGF-1 LR3 is one analog with extended pharmacokinetic properties

Complementary contributing factors encompass genetic predisposition, dysregulated inflammatory pathways, and metabolic comorbidities, which collectively modulate disease expression and progression (Figure 2